WHC is still in active development. Read this to understand our approach.
depiction of OTQWCDNEJVKXKG-UHFFFAOYSA-N.svg
tripsit

lsm-775

Verificar en tripsit

psychonaut

LSM-775

Verificar en psychonaut

isomerdesign

LSM-775

Verificar en isomerdesign

druglab

LSM-775

Verificar en druglab

wiki

LSM-775

Verificar en wiki

Data

InChI: InChI=1S/C20H23N3O2/c1-22-12-14(20(24)23-5-7-25-8-6-23)9-16-15-3-2-4-17-19(15)13(11-21-17)10-18(16)22/h2-4,9,11,14,18,21H,5-8,10,12H2,1H3

Sinónimos: ((6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl)(morpholino)methanone,LSM,LA-Morph,4-Lysergic acid morpholide,Ergoline-8-beta-carboxylic acid, 9,10-didehydro-6-methyl-, morpholide,UNII-168Y0PXM7S,MORPHOLINE, 4-(((8.BETA.)-9,10-DIDEHYDRO-6-METHYLERGOLIN-8-YL)CARBONYL)-,Lysergic acid morpholide,4314-63-0,D-Lysergic acid morpholide,LSM-75 Isomer I,lsm,[(6aR,9R)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinolin-9-yl]-morpholin-4-ylmethanone,4-Lysergoylmorpholine,(7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl)(morpholin-4-yl)methanone,Morpholine, 4-(((8-beta)-9,10-didehydro-6-methylergolin-8-yl)carbonyl)-,DTXSID50195718,N-Morpholinyllysergamide,168Y0PXM7S,LSM-775,4-Lysergic acid morpholine,Morpholine, 4-lysergoyl-,L-2,SCHEMBL20970864,Morpholine lysergamide,Q6459970

Estimated data

Solubilidad: -2.632 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 85.9% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.